Oppenheimer & CO Inc Crispr Therapeutics Ag Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Oppenheimer & CO Inc holds 34,128 shares of CRSP stock, worth $1.52 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

34,128

Previous 31,650 7.83%

Holding current value

$1.52 Million

Previous $1.71 Million 6.2%

% of portfolio

0.02%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$44.62 - $62.75 $110,568 - $155,494	2,478 Added 7.83%	34,128 $1.6 Million
Q2 2024 Aug 07, 2024	BUY	$51.17 - $68.18 $100,190 - $133,496	1,958 Added 6.59%	31,650 $1.71 Million
Q1 2024 May 06, 2024	BUY	$60.67 - $89.12 $197,602 - $290,263	3,257 Added 12.32%	29,692 $2.02 Million
Q4 2023 Feb 13, 2024	BUY	$38.62 - $72.18 $171,356 - $320,262	4,437 Added 20.17%	26,435 $1.65 Million
Q3 2023 Nov 07, 2023	BUY	$45.39 - $59.0 $135,035 - $175,525	2,975 Added 15.64%	21,998 $998,000
Q2 2023 Aug 02, 2023	BUY	$43.47 - $67.77 $46,904 - $73,123	1,079 Added 6.01%	19,023 $1.07 Million
Q1 2023 May 10, 2023	SELL	$41.0 - $56.12 $32,882 - $45,008	-802 Reduced 4.28%	17,944 $811,000
Q4 2022 Feb 07, 2023	SELL	$39.19 - $65.67 $40,404 - $67,705	-1,031 Reduced 5.21%	18,746 $762,000
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $96,171 - $131,869	1,574 Added 8.65%	19,777 $1.29 Million
Q2 2022 Aug 08, 2022	BUY	$43.23 - $73.83 $50,233 - $85,790	1,162 Added 6.82%	18,203 $1.11 Million
Q1 2022 May 12, 2022	SELL	$53.19 - $79.24 $119,996 - $178,765	-2,256 Reduced 11.69%	17,041 $1.07 Million
Q4 2021 Feb 02, 2022	SELL	$70.09 - $111.29 $87,542 - $139,001	-1,249 Reduced 6.08%	19,297 $1.46 Million
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $371,043 - $527,406	3,367 Added 19.6%	20,546 $2.3 Million
Q2 2021 Aug 03, 2021	BUY	$100.84 - $161.89 $669,073 - $1.07 Million	6,635 Added 62.93%	17,179 $2.78 Million
Q1 2021 May 10, 2021	BUY	$110.72 - $210.04 $161,208 - $305,818	1,456 Added 16.02%	10,544 $1.29 Million
Q4 2020 Feb 11, 2021	SELL	$79.67 - $173.23 $20,953 - $45,559	-263 Reduced 2.81%	9,088 $1.39 Million
Q3 2020 Nov 13, 2020	SELL	$78.5 - $100.64 $50,161 - $64,308	-639 Reduced 6.4%	9,351 $782,000
Q2 2020 Aug 11, 2020	SELL	$38.5 - $76.05 $32,725 - $64,642	-850 Reduced 7.84%	9,990 $734,000
Q1 2020 May 08, 2020	BUY	$33.68 - $62.53 $230,404 - $427,767	6,841 Added 171.07%	10,840 $460,000
Q4 2019 Feb 07, 2020	BUY	$36.68 - $73.13 $146,683 - $292,446	3,999 New	3,999 $244,000
Q2 2019 Aug 09, 2019	SELL	$35.45 - $48.2 $257,154 - $349,642	-7,254 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$28.02 - $40.87 $203,257 - $296,470	7,254 New	7,254 $259,000
Q4 2018 Jan 29, 2019	SELL	$22.73 - $42.34 $140,971 - $262,592	-6,202 Closed	0 $0
Q3 2018 Oct 26, 2018	BUY	$44.35 - $65.71 $275,058 - $407,533	6,202 New	6,202 $275,000

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.48B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account

Oppenheimer & CO Inc Crispr Therapeutics Ag Transaction History